Infosys Ltd. reported its financial results for the first quarter of fiscal year 2026, posting a net profit of ₹6,921 crore, reflecting an 8.7% increase year-over-year. The company's revenue rose 7.5% to ₹42,279 crore, with constant currency terms showing a 3.8% year-over-year growth. Operating profit reached ₹8,803 crore, up 6.2% year-over-year, and the operating margin is expected to be between 20% and 22% for FY26. Attrition increased slightly to 14.4% from 14.1%. Infosys also announced large deal wins totaling $3.8 billion, with 55% classified as net new, indicating strong client demand despite modest revenue growth. The company maintained strong cash flow and raised its revenue outlook for the fiscal year. Cipla, India's third-largest drugmaker by sales, reported a 10.2% year-over-year increase in consolidated net profit to ₹1,298 crore for Q1 FY26, driven by higher domestic demand for generic respiratory drugs and growth in its US business, which contributed $226 million. Cipla's revenue reached ₹6,957 crore, with domestic revenue exceeding ₹3,000 crore and growing 6%, supported by chronic therapies. Paras Defence and Space Technologies posted an 11.5% year-over-year increase in revenue to ₹93.19 crore but saw a 13.9% quarter-over-quarter decline. Profit after tax (PAT) rose slightly by 1.13% year-over-year to ₹14.27 crore but declined 31.49% quarter-over-quarter. Intellect Design reported a 27% year-over-year increase in net profit to ₹94.4 crore, with revenue up 16% to ₹702 crore and EBITDA rising 18% to ₹143 crore. The company's margin improved to 20.4% from 20% year-over-year.